Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
›
topic: Tuberculosis
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
Read More
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
Read More
Activists interrupt TB conference opening ceremony to call on J&J to cut price of TB drug in half, to one dollar per day
Read More
MSF warns high prices of tuberculosis drugs restrict people´s access to best drug-resistant TB treatment
Read More
MSF response to first-ever UN tuberculosis summit
Read More
Global leaders must make bold commitments at first-ever UN tuberculosis summit
Read More
MSF applauds the World Health Organization’s move to recommend improved tuberculosis treatment options
Read More
Last-minute pressured to drop language on protecting access to affordable meds from TB Summit declaration negotiations
Read More
MSF responds to India’s first-ever national anti-tuberculosis drug resistance survey
Read More
Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai
Read More